The American pharmaceutical giant Pfizer and the German biotech firm BioNTech reported on Monday in a press release that their joint Covid-19 vaccine candidate, BNT162b2, is more than 90 percent effective...
Explore Related Collections
Popular stories about Is Pfizer
- Vox - Umair Irfan
- The Guardian - Nicola Davis Science correspondent
Early results from phase 3 trial look promising but there are still many questions to be answered Pfizer and the German biotech company BioNTech said on Monday that they had had encouraging early results...
- The New York Times - Katie Thomas
Correction: November 17, 2020 This article has been revised to reflect the following correction: An earlier version of this article misstated the storage temperature for Moderna's vaccine. It can be stored...
- By New Scientist
Early results suggest a coronavirus vaccine candidate is “more than 90% effective in preventing covid-19”, but is it really the breakthrough we hope for? Plus: what a Biden presidency means for covid-19, climate change and tech.